Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Key topics included the effectiveness of oral semaglutide in clinical practice, the positioning of the agent to optimize the treatment benefits, the possibility to adopt flexibility in the administration schedule, critical issues encountered, the role of patient communication and information in the importance of dose escalation and management of adverse events
8, 19 Fig
Semaglutide belongs to the fast-growing class of GLP-1 therapies used for the treatment of type 2 diabetes and obesity
Retrieved August 1, 2026
References Agrawal U, Gupta M et al (2013) Options and opportunities for clinical management and treatment of psoriasis
The dual amylin and calcitonin receptor agonist KBP-336 elicits a unique combination of weight loss, antinociception and bone protection a novel disease-modifying osteoarthritis drug
